Novo Nordisk Operating Income 2010-2025 | NVO

Novo Nordisk operating income for the twelve months ending March 31, 2025 was $19.446B, a 22.09% increase year-over-year.

  • Novo Nordisk annual operating income for 2024 was $18.609B, a 24.95% increase from 2023.
  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
  • Novo Nordisk annual operating income for 2022 was $10.593B, a 13.53% increase from 2021.

Novo Nordisk Operating Income 2010-2025 | NVO

  • Novo Nordisk annual operating income for 2024 was $18.609B, a 24.95% increase from 2023.
  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
  • Novo Nordisk annual operating income for 2022 was $10.593B, a 13.53% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B